195 related articles for article (PubMed ID: 23461966)
41. Lower nodal counts in axillary dissection following neoadjuvant chemotherapy: are there implications?
Callcut RA; Breslin TM
Am J Surg; 2006 Jun; 191(6):830-1. PubMed ID: 16720160
[No Abstract] [Full Text] [Related]
42. [Sentinel lymph node biopsy and low axillary node sampling for breast cancer].
Sawai K; Nakajima H; Ohe S; Mizuta N; Sakaguchi K; Hachimine Y
Nihon Geka Gakkai Zasshi; 2002 Nov; 103(11):825-30. PubMed ID: 12478860
[TBL] [Abstract][Full Text] [Related]
43. Pathological examination of sentinel lymph node in breast cancer: potential problems and possible solutions.
Hoda SA; Chiu A; Resetkova E; Harigopal M; Hoda RS; Osborne MP
Microsc Res Tech; 2002 Oct; 59(2):85-91. PubMed ID: 12373718
[TBL] [Abstract][Full Text] [Related]
44. Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment?
Port ER; Patil S; Stempel M; Morrow M; Cody HS
Cancer; 2010 Apr; 116(8):1987-91. PubMed ID: 20151427
[TBL] [Abstract][Full Text] [Related]
45. Extensive nodal involvement increases the positivity of blue nodes in the axillary reverse mapping procedure in patients with breast cancer.
Rubio IT; Cebrecos I; Peg V; Esgueva A; Mendoza C; Cortadellas T; Cordoba O; Espinosa-Bravo M; Xercavins J
J Surg Oncol; 2012 Jul; 106(1):89-93. PubMed ID: 22258666
[TBL] [Abstract][Full Text] [Related]
46. [What is new about sentinel lymph node biopsy in breast cancer?].
Houvenaeghel G; Buttarelli M; Rossi I; Tallet A; Jacquemier J; Viens P
Bull Cancer; 2004 Dec; 91 Suppl 4():S216-20. PubMed ID: 15899611
[TBL] [Abstract][Full Text] [Related]
47. Axillary recurrence in breast cancer patients with isolated tumor cells in the sentinel lymph node [AJCC N0(i+)].
Degnim AC; Zakaria S; Boughey JC; Sookhan N; Reynolds C; Donohue JH; Farley DR; Grant CS; Hoskin T
Ann Surg Oncol; 2010 Oct; 17(10):2685-9. PubMed ID: 20390457
[TBL] [Abstract][Full Text] [Related]
48. Preoperative axillary lymph node staging in early breast cancer: Diagnostic efficacy and histopathology correlation.
Ferreira da Silva F; de Lurdes Orvalho M; Gaspar A; Viana Lopes P; Leal de Faria J; Catarino A; Nave M; Passos-Coelho JL
Breast J; 2019 Nov; 25(6):1312-1315. PubMed ID: 31338924
[No Abstract] [Full Text] [Related]
49. Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients.
Qiu PF; Liu JJ; Wang YS; Yang GR; Liu YB; Sun X; Wang CJ; Zhang ZP
Jpn J Clin Oncol; 2012 Nov; 42(11):1002-7. PubMed ID: 23100610
[TBL] [Abstract][Full Text] [Related]
50. Sentinel node biopsy in breast cancer revisited.
Omair M; Al-Azawi D; Mann GB
Surgeon; 2014 Jun; 12(3):158-65. PubMed ID: 24548701
[TBL] [Abstract][Full Text] [Related]
51. [Sentinel lymph nodes in breast cancer].
Mustonen P; Vanninen E
Duodecim; 2001; 117(2):192-8; quiz 199, 211. PubMed ID: 12092373
[No Abstract] [Full Text] [Related]
52. Axillary lymph node dissection using a robotic surgical system: Initial experience.
Lee J; Park HS; Lee H; Lee K; Han DH; Lee DW
J Surg Oncol; 2020 Nov; 122(6):1252-1256. PubMed ID: 32783194
[No Abstract] [Full Text] [Related]
53. [Clinicopathologic issues related to sentinel lymph node biopsy in breast cancer patients].
Li DL; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):725-8. PubMed ID: 21215160
[No Abstract] [Full Text] [Related]
54. ASO Visual Abstract: Implementation of the Targeted Axillary Dissection Procedure in Clinically Node-Positive Breast Cancer-A Retrospective Analysis.
Nijveldt JJ; Rajan KK; Boersma K; Noorda EM; van der Starre-Gaal J; van 't Veer-Ten Kate M; Roeloffzen EMA; Vendel BN; Beek MA; Francken AB
Ann Surg Oncol; 2024 Jul; 31(7):4543-4544. PubMed ID: 38710908
[No Abstract] [Full Text] [Related]
55. [Report from The 3rd International Sentinel Node Congress, Yokohama, November 16-18, 2002].
Gábor P; Ferenc RV; Gabriella L; Gábor C
Magy Seb; 2003 Apr; 56(2):90-1. PubMed ID: 12848107
[No Abstract] [Full Text] [Related]
56. Breast cancer and the NSABP-B32 sentinel node trial.
Krag D; Harlow S; Julian T
Breast Cancer; 2004; 11(3):221-4; discussion 264-6. PubMed ID: 15550839
[No Abstract] [Full Text] [Related]
57. Surgical management of the axilla in early breast cancer.
Jatoi I; Benson JR
Curr Probl Surg; 2018 Feb; 55(2):47-65. PubMed ID: 29555055
[No Abstract] [Full Text] [Related]
58. Management of the positive axilla in 2017.
Avisar E; Ozmen T
Breast Cancer Res Treat; 2017 Jun; 163(3):413-415. PubMed ID: 28382401
[No Abstract] [Full Text] [Related]
59. Expanding indications for lymphatic mapping and sentinel lymph node biopsy in the breast cancer population.
Reintgen D
Ann Surg Oncol; 2001 Oct; 8(9):687. PubMed ID: 11597007
[No Abstract] [Full Text] [Related]
60. Lymphatic mapping/sentinel lymphadenectomy.
Bleicher RJ; Sigurdson ER
Curr Probl Cancer; 2012; 36(5):263-91. PubMed ID: 22867920
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
